Centenara Labs AG
PrivateLast Round
Series B
Sep 11, 2023
Total Funding Raised
$75M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Centenara Labs AG operates in Healthcare & Life Sciences and is based in Schlieren. Its latest recorded funding round was a Series B round in September 2023.
Centenara Labs AG is a biotechnology company that operates an integrated platform to develop therapies and fund startups focused on healthy aging and age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Centenara Labs AG Comparables
Compare Centenara Labs AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Life Biosciences | 83% | |
| HAYA Therapeutics | 81% | |
| Turn Biotechnologies | 81% |
For institutional investors. Book with your work email.
Centenara Labs AG Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Centenara Labs AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gaingels | Series A |
| Catalio Capital Management | Series B |
| Coeli Asset Management | Series A |
| Apeiron Investment Group | Series B |
| Mubadala Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 130% MoM, reaching 2.3K.
For institutional investors. Book with your work email.
Centenara Labs AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Centenara Labs AG's valuation, stock price, and market status.
Is Centenara Labs AG a public or private company?
Centenara Labs AG is a private company.
What is the current stock price of Centenara Labs AG?
Centenara Labs AG is a private company, so its shares have no public market price. Caplight tracks Centenara Labs AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Centenara Labs AG worth (valuation)?
Valuation information for Centenara Labs AG is not publicly available.
Can I buy Centenara Labs AG stock?
Centenara Labs AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Centenara Labs AG's last funding round?
Centenara Labs AG's most recent funding round was Series B on September 11, 2023.
Who are the main investors in Centenara Labs AG?
Key investors in Centenara Labs AG include Catalio Capital Management, Apeiron Investment Group.
Will Centenara Labs AG IPO soon?
No public IPO plans have been announced for Centenara Labs AG.
How can I track Centenara Labs AG secondary market activity?
Caplight tracks bids, offers, and trades in Centenara Labs AG's shares on secondary markets.